Gynecomastia associated with low-dose methotrexate therapy for rheumatoid arthritis.
Mod Rheumatol
; 17(6): 511-3, 2007.
Article
en En
| MEDLINE
| ID: mdl-18084706
ABSTRACT
A 68-year-old man with a 3-year history of rheumatoid arthritis (RA) developed gynecomastia 3 months after beginning oral low-dose methotrexate (MTX) therapy. Four months after MTX therapy was discontinued, the gynecomastia symptoms improved. Only eight cases of gynecomastia resulting from low-dose MTX administration have been reported worldwide, and no cases have previously been reported in Japan. Although it occurs infrequently, gynecomastia resulting from low-dose MTX therapy should be considered in male patients with RA.
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Artritis Reumatoide
/
Metotrexato
/
Antirreumáticos
/
Ginecomastia
Tipo de estudio:
Diagnostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Mod Rheumatol
Año:
2007
Tipo del documento:
Article